United Therapeutics Corporation (UTHR)
NASDAQ·Healthcare·Biotechnology
$585.06
-1.04%
Mkt Cap $23.76B
Analyst Ratings
Buy
9
Hold
2
Sell
0
Price Target (39 analysts)
$650.00
Range $515.00 – $735.00
Implied Upside
+11.1%
Consensus $650.00 vs current $585.06